CMC Stock Cash Flow Statements

Commercial Metals Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Capital Expenditure

Commercial Metals Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-05-31	2025-02-28	2024-11-30	2024-08-31	2024-05-31	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2022-08-31	2022-05-31	2022-02-28	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2015-08-31	2015-05-31	2015-02-28	2014-11-30	2014-08-31	2014-05-31	2014-02-28	2013-11-30	2013-08-31	2013-05-31	2013-02-28	2012-11-30	2012-08-31	2012-05-31	2012-02-29	2011-11-30	2011-08-31	2011-05-31	2011-02-28	2010-11-30	2010-08-31	2010-05-31	2010-02-28	2009-11-30	2009-08-31	2009-05-31	2009-02-28	2008-11-30	2008-08-31	2008-05-31	2008-02-29	2007-11-30	2007-08-31	2007-05-31	2007-02-28	2006-11-30	2006-08-31	2006-05-31	2006-02-28	2005-11-30	2005-08-31	2005-05-31	2005-02-28	2004-11-30	2004-08-31	2004-05-31

cash flows from (used by) operating activities:
net earnings	83,126,000	25,473,000	-175,718,000	103,931,000	119,440,000	85,847,000	176,273,000	184,166,000	233,971,000	288,630,000	312,429,000	383,314,000	232,889,000	152,313,000	130,102,000	66,357,000	64,093,000	67,623,000	64,734,000	63,798,000	83,348,000	86,111,000	78,390,000	13,850,000	19,742,000	51,560,000	39,966,000	10,170,000	36,810,000	-29,541,000	39,266,000	30,332,000	6,275,000	-131,000	19,328,000	10,502,000	25,063,000	-5,751,000	56,681,000	54,451,000	36,253,000	34,926,000	23,563,000	11,144,000	45,919,000	4,060,000	18,963,000	4,577,000	49,719,000	30,218,000	40,683,000	28,853,000	107,736,000				742,000	7,959,000	-8,463,000	-173,381,000	-31,223,000	7,180,000	-13,077,000	-35,307,000	62,006,000	63,543,000	59,484,000	39,775,000	69,164,000	104,719,000	99,441,000	65,921,000	85,350,000	128,660,000	77,960,000	80,103,000	69,624,000	83,740,000	71,741,000	56,575,000	73,725,000	47,354,000	50,884,000
adjustments to reconcile net earnings to cash flows from operating activities:
depreciation and amortization	72,376,000	70,584,000	70,437,000	72,190,000	70,692,000	68,299,000	69,186,000	61,302,000	55,129,000	49,081,000	43,583,000	41,134,000	41,226,000	42,437,000	41,804,000	41,573,000	41,799,000	41,654,000	41,766,000	41,391,000	40,947,000	41,054,000	41,187,000	41,248,000	35,182,000	32,216,000	33,127,000	34,123,000	32,193,000	32,022,000	32,260,000	30,499,000	30,290,000	31,517,000	31,882,000	31,550,000	31,991,000	32,950,000	32,841,000	33,129,000	33,859,000	34,874,000	33,846,000	33,424,000	33,860,000	34,384,000	34,127,000	34,286,000	33,751,000	33,369,000	34,877,000	34,036,000	35,028,000	38,766,000	39,179,000	40,988,000	40,643,000	40,541,000	40,017,000	44,681,000	43,695,000	38,634,000	37,470,000	37,267,000	41,308,000	38,475,000	32,721,000	32,351,000	31,522,000	31,446,000	26,838,000	23,855,000	25,166,000	23,856,000	21,844,000	20,408,000	19,270,000	19,854,000	18,910,000	18,708,000	19,138,000	18,716,000	18,335,000
stock-based compensation	9,546,000	8,038,000	10,232,000	9,173,000	12,846,000	14,988,000	8,059,000	16,529,000	10,376,000	9,122,000	11,986,000	16,251,000	9,619,000	8,119,000	13,800,000	12,696,000	9,062,000		6,170,000	7,536,000	8,269,000		7,343,000	5,790,000	4,217,000		4,909,000	8,558,000	4,780,000		3,560,000	7,911,000	8,245,000		6,783,000	6,840,000	6,266,000		6,466,000	6,094,000	5,728,000
write-down of inventory	4,930,000	6,785,000	8,950,000	-1,488,000	-3,806,000	-263,000	10,655,000	2,355,000	3,399,000																													4,238,000	9,771,000							693,000	526,000	721,000	1,063,000	4,612,000	845,000	2,553,000	5,907,000	17,910,000	2,369,000	1,409,000	3,815,000	8,523,000	8,187,000
deferred income taxes and other long-term taxes	873,000	-18,150,000	-76,940,000	-11,253,000	-5,967,000	-19,442,000	21,343,000	17,104,000	7,885,000	21,934,000	29,261,000	40,079,000	-5,099,000	-22,698,000	-9,046,000	-19,849,000	11,720,000	1,819,000	5,619,000			13,156,000	24,662,000	12,057,000	-352,000
litigation expense	3,776,000	4,720,000	350,000,000
settlement of new markets tax credit transaction								0	0
asset impairments								3,734,000	1,000	453,000	3,245,000			2,439,000	277,000	474,000	3,594,000	1,098,000
other	1,059,000	2,510,000	-185,000	-939,000	1,459,000	1,123,000	1,102,000	-309,000	774,000	1,104,000	614,000	1,418,000	-583,000	298,000	348,000	-135,000	30,000	-1,917,000	362,000	396,000	1,175,000	0
changes in operating assets and liabilities	-19,671,000	-67,519,000	26,248,000								-211,715,000	-196,805,000	-252,273,000		-78,839,000	-97,745,000	-140,794,000		157,492,000	-15,477,000	-196,000		5,387,000	-44,476,000	-36,333,000		-49,995,000
net cash flows from operating activities	154,400,000	32,441,000	213,024,000	351,817,000	197,870,000	88,961,000	261,060,000	409,424,000	375,772,000	458,562,000	187,379,000			134,242,000	93,029,000											67,035,000	42,858,000			155,558,000	6,931,000			79,997,000								42,635,000																	4,024,000	-18,420,000	31,891,000									338,928,000	34,586,000	45,732,000	42,044,000	136,635,000
cash flows from (used by) investing activities:
capital expenditures	-89,450,000	-86,267,000	-118,187,000	-81,468,000	-82,031,000	-93,781,000	-66,991,000	-166,923,000	-150,491,000	-155,642,000	-102,784,000	-121,412,000	-70,150,000	-56,770,000	-39,707,000	-50,487,000	-37,201,000	-53,526,000	-37,500,000	-51,033,000	-45,559,000	-47,083,000	-24,256,000	-29,583,000	-37,914,000	-30,387,000	-43,240,000	-41,347,000	-59,681,000	-51,038,000	-71,274,000	-47,843,000	-42,965,000	-58,851,000	-42,044,000	-51,268,000	-11,169,000	-43,604,000	-26,478,000	-27,048,000	-22,450,000	-34,031,000	-31,495,000	-22,138,000	-14,085,000	-26,027,000	-21,159,000	-17,092,000	-24,757,000	-31,348,000	-29,132,000	-23,448,000	-29,925,000	-21,676,000	-28,472,000	-11,163,000	-11,904,000	-17,657,000	-22,118,000	-40,832,000	-46,514,000	-79,376,000	-80,701,000	-122,963,000	-86,654,000
free cash flows
proceeds from government assistance related to property, plant and equipment	0
proceeds from the sale of property, plant and equipment	169,000	103,000	5,167,000														743,000	-2,248,000	87,000	4,353,000	9,651,000	1,407,000	461,000
net cash flows used by investing activities	-87,477,000	-61,657,000	-113,487,000	-82,055,000	-82,487,000	-91,987,000	-66,473,000	-230,065,000		-155,972,000			-68,732,000													-49,817,000	40,117,000	2,623,000	-63,598,000	93,416,000	-113,214,000	-68,264,000	-25,653,000	-25,542,000	-41,583,000	-100,166,000	-8,356,000					-38,592,000																								-325,245,000	-91,643,000
cash flows from (used by) financing activities:
proceeds from issuance of long-term debt										2,988,000	0			92,000	12,937,000			39,973,000	11,267,000			0	0	0	180,000,000																					0									824,000	594,000	45,000	1,000	944,000	20,799,000	694,000													313,000	8,142,000	-5,366,000	11,406,000					0	38,400,000
repayments of long-term debt	-10,162,000	-9,301,000	-10,940,000	-8,862,000	-10,285,000	-7,923,000	-9,276,000	-9,056,000	-220,437,000	-8,888,000	-6,532,000	-306,618,000	-6,556,000	-6,672,000	-4,063,000	-353,969,000	-3,823,000	-136,053,000	-3,590,000	-53,582,000	-53,298,000	-103,566,000	-9,533,000	-7,430,000	-7,175,000
debt issuance costs	-568,000	0	-38,000					0	0	0	-87,000			0	-1,706,000											0
proceeds from accounts receivable facilities	16,455,000	0	13,303,000	33,307,000	103,936,000	28,658,000	9,421,000	87,653,000	167,445,000	112,571,000	136,935,000	40,066,000	150,664,000	150,722,000
repayments under accounts receivable facilities	-16,455,000	0	-13,303,000	-61,063,000	-76,591,000	-28,222,000	-17,471,000	-104,910,000	-166,262,000	-143,270,000	-75,470,000	-70,490,000	-144,706,000	-151,546,000
treasury stock acquired	-50,421,000	-48,016,000	-50,417,000	-54,768,000	-51,817,000	-47,939,000	-28,408,000	-18,567,000	-16,516,000	-106,283,000	-38,587,000	-11,699,000	-5,311,000																					0	0	-26,040,000	-4,555,000	0	-2,226,000	-30,239,000	-9,341,000																					0	0	0	-18,514,000	-20,782,000	0	-100,339,000	-51,191,000	-41,425,000	0							-26,402,000
tax withholdings related to share settlements, net of purchase plans	705,000	9,304,000	-19,560,000	968,000	664,000	10,308,000	-19,535,000	1,126,000	1,124,000
dividends	-20,319,000	-20,427,000	-20,554,000	-20,679,000	-20,815,000	-18,626,000	-18,748,000	-18,679,000	-18,733,000	-16,746,000	-16,992,000	-16,986,000	-17,025,000	-14,471,000	-14,462,000	-14,427,000	-14,406,000		-14,288,000	-14,242,000	-14,238,000		-14,206,000	-14,065,000	-14,116,000
contribution from non-controlling interest				0				0
net cash flows used by financing activities	66,971,000	-68,440,000	-101,509,000		-54,901,000	-63,744,000	-84,017,000						-39,305,000	-21,233,000	20,910,000	-80,497,000	-28,570,000											-21,121,000	-24,351,000	-271,307,000	-13,912,000	-15,244,000	-24,030,000	-20,229,000			-58,886,000														-44,354,000	-27,021,000	-992,000			-102,449,000	-50,094,000
effect of exchange rate changes on cash	1,808,000	194,000	-695,000	380,000	131,000	-439,000	819,000	107,000	425,000	-923,000	-579,000	-733,000	-550,000	-367,000	-4,000	-54,000	-365,000	549,000	-127,000	141,000	196,000	-257,000	-120,000	132,000	-353,000	-242,000	-710,000	484,000	-235,000	-850,000	427,000	950,000	-1,740,000	-537,000	436,000	-713,000	-466,000	-1,605,000	-309,000	-1,654,000	-1,980,000	-60,000	377,000	-466,000	1,022,000	-1,344,000	-677,000	218,000	1,525,000	3,687,000	-8,072,000	5,261,000	-7,658,000	-631,000	1,474,000	1,948,000	1,081,000	1,142,000	-3,155,000	-589,000	397,000	877,000	490,000	-949,000	-5,946,000		1,277,000	713,000	1,465,000			-96,000	471,000		1,571,000	1,525,000	-354,000	-132,000	-905,000	340,000	1,314,000	30,000	2,105,000
increase in cash, restricted cash and cash equivalents	135,702,000	-97,462,000	-2,667,000		60,613,000	-67,209,000	111,389,000		-129,733,000		-463,171,000				77,280,000	-98,152,000	-77,481,000		230,284,000	8,023,000	32,130,000
cash, restricted cash and cash equivalents at beginning of period	0	0	859,555,000	0	0	0	595,717,000	0	0	0	0	0	501,129,000		0	0	544,964,000		0	0	193,729,000		0	0	632,615,000
cash, restricted cash and cash equivalents at end of period	135,702,000	-97,462,000	856,888,000	159,045,000	60,613,000	-67,209,000	707,106,000	117,032,000	-129,733,000	142,714,000	-463,171,000	581,379,000	418,321,000		77,280,000	-98,152,000	467,483,000		230,284,000	8,023,000	225,859,000		54,143,000	10,626,000	57,537,000
adjustments to reconcile net earnings to net cash flows from operating activities:
net gain on sales of assets								1,152,000
loss on debt extinguishment								1,000	0	0	0			0	0																			0	115,000											3,256,000
settlement of new markets tax credit transactions
changes in operating assets and liabilities, net of acquisitions:
accounts receivable																														8,141,000	-88,830,000	-27,923,000	30,085,000	-3,656,000	-44,456,000	23,961,000	166,661,000	116,221,000	-47,720,000	37,646,000	100,486,000	-83,918,000	-79,674,000	-52,857,000	73,052,000	23,254,000	-16,974,000																			21,116,000	-218,764,000			19,988,000	-101,828,000	-96,267,000	138,412,000	-99,384,000	-123,402,000	-87,240,000	12,102,000	-4,697,000	-130,503,000	-35,769,000	-46,429,000	44,624,000	-125,741,000
inventories																														35,885,000	-66,264,000	-79,134,000	10,678,000	3,838,000	94,173,000	32,844,000	78,700,000	162,422,000	140,755,000	-149,476,000	-102,954,000	-565,000	37,552,000	-184,529,000	-29,789,000	58,780,000	52,519,000																			-175,893,000	-190,260,000			138,712,000	-56,640,000	-1,675,000	-90,778,000	-25,782,000	47,553,000	-105,424,000	47,457,000	35,101,000	14,841,000	2,842,000	-102,097,000	-127,651,000	-21,306,000
accounts payable, accrued expenses and other payables																														10,123,000	73,981,000	79,764,000	-70,390,000	21,099,000	50,326,000	-38,553,000	-76,449,000	-51,195,000	31,306,000	-99,336,000	-61,292,000	52,276,000	60,189,000	9,673,000	-31,534,000	60,655,000
other operating assets and liabilities
acquisitions, net of cash acquired								-67,648,000	-101,916,000	0								-8,287,000	0			0	41,000	-6,180,000	-694,802,000																																	0	0	0	-2,448,000	0					-9,606,000	-2,283,000	-18,757,000
proceeds from government grants related to property, plant and equipment
proceeds from insurance								0	0	0	0											0	500,000
proceeds from the sale of property, plant and equipment and other								230,000	245,000	177,000	5,408,000	308,145,000	1,418,000	534,000	5,552,000										1,953,000		5,684,000	71,000	560,000		1,184,000	521,000	179,000	1,643,000	410,000	247,000	2,813,000	4,782,000	1,870,000	7,391,000	882,000	10,799,000	392,000	4,255,000	2,126,000	2,740,000	4,267,000	941,000	5,956,000	43,989,000	3,274,000	1,083,000	7,014,000	1,141,000	381,000	354,000	51,518,000	17,600,000	4,831,000	273,000	183,000	328,000	-2,550,000	4,044,000	798,000
debt issuance and extinguishment
net cash flows from (used by) financing activities								-62,434,000	-253,370,000	-158,953,000	-146,000							-115,061,000	-10,593,000	-42,776,000	-79,360,000			41,432,000	140,342,000	-18,091,000												-135,405,000	-105,151,000	68,116,000	-8,251,000	-6,268,000	-21,740,000	-26,292,000	19,903,000	-180,077,000	206,506,000	-42,925,000	31,526,000					-29,146,000												467,756,000
increase in cash and cash equivalents																										-1,115,000						-69,621,000	-52,377,000				151,865,000	104,317,000	68,005,000	-13,074,000	-108,850,000	-2,285,000	5,456,000	-83,719,000	136,703,000	-74,499,000			8,974,000	28,763,000			5,713,000					109,683,000				-35,786,000				150,448,000				346,150,000			-23,368,000	57,541,000			14,074,000			45,301,000	-79,685,000
changes in operating assets and liabilities, net of acquisitions					3,206,000	-61,591,000	-25,558,000		63,449,000
debt extinguishment costs								-1,000	0	0	0			0	-77,000																				-114,000											-3,055,000
amortization of acquired unfavorable contract backlog														-1,495,000	-1,508,000	-1,509,000	-1,523,000	-10,691,000	-4,348,000	-5,997,000	-8,331,000	-16,582,000	-23,394,000	-23,476,000	-11,332,000
net gain on disposals of assets
net cash flows from (used by) investing activities																									-357,444,000														-24,608,000	-20,148,000	-18,723,000			-19,872,000	42,306,000		-16,892,000	-16,151,000	10,194,000		-25,858,000	8,904,000	-23,776,000		-28,956,000	-7,455,000	38,091,000
net gain on disposals of subsidiaries, assets and other														583,000	-3,909,000	-5,412,000	-69,000		109,000	1,148,000	-6,733,000				-1,271,000
adjustments to reconcile net earnings to cash flows from (used by) operating activities:
stock issued under incentive and purchase plans, net of forfeitures											587,000	5,652,000	-16,371,000	641,000	729,000	5,805,000	-10,341,000	-1,499,000	542,000	5,354,000	-7,817,000	488,000	492,000	3,364,000	-6,220,000	534,000	-2,442,000	2,126,000	-9,520,000	18,000	-108,000	2,253,000	-7,661,000	2,000	-365,000	1,957,000	-7,628,000	-103,000	-12,000	1,604,000	-2,981,000	-628,000	-120,000	1,349,000	-2,089,000	-396,000	-1,006,000	2,767,000	-414,000
net gain on disposals of assets and other
net cash flows from (used by) operating activities													25,779,000				-12,088,000	259,371,000	278,417,000	106,998,000	146,418,000												-954,000			113,237,000	219,573,000		198,073,000	-59,388,000	-79,896,000			-37,089,000	73,472,000		94,235,000	-42,441,000	-34,271,000		95,761,000	935,000	38,139,000		-28,652,000	-9,823,000	-5,591,000					137,712,000	379,760,000	285,072,000	3,992,000	10,113,000	-4,038,000	-7,062,000	-42,469,000							-46,588,000	71,663,000
decrease in cash, restricted cash and cash equivalents													-82,808,000											10,626,000	-575,078,000
beneficial interest in securitized accounts receivable																						0	0	0	-367,521,000
contribution from noncontrolling interest														1,000	0
cash, restricted cash and cash equivalents at beginning of year
cash, restricted cash and cash equivalents at end of year
net cash flows used by investing activities:															-36,655,000	-30,892,000	-36,458,000		-37,413,000	-56,340,000	-35,124,000
proceeds from accounts receivable programs																4,361,000	4,487,000	63,349,000	85,447,000	58,636,000	27,050,000	65,753,000	83,073,000
repayments under accounts receivable programs																-4,361,000	-4,487,000		-89,971,000	-50,257,000	-31,057,000
share-based compensation																																										1,997,000	5,266,000	5,244,000	5,544,000	5,165,000	6,343,000	2,676,000	4,509,000	3,929,000	3,223,000	2,092,000	3,881,000		3,214,000	3,891,000	2,135,000	7,542,000	15,000	3,153,000	2,422,000	5,106,000	3,603,000	4,657,000	4,109,000	4,194,000	5,734,000	4,862,000	4,206,000	5,118,000	2,023,000	3,059,000	2,299,000	2,551,000	2,551,000	2,491,000	1,933,000
net gain on sales of a subsidiary, assets and other
write-down of inventory and other
benefit from losses on receivables																						288,000				317,000	145,000	147,000	1,901,000	5,193,000	-525,000	-147,000	1,528,000	3,130,000	1,008,000	669,000	2,071,000	956,000	1,254,000	1,366,000	-95,000	-55,000			-240,000				1,153,000														10,237,000	14,594,000	8,784,000		2,822,000	819,000	605,000		598,000	-592,000	633,000	514,000	321,000	1,159,000	682,000	3,030,000	562,000	2,057,000	955,000	711,000	1,653,000
proceeds from insurance, sale of discontinued operations and other																		0	0	190,000	784,000
advances under accounts receivable programs
cash dividends																										-14,040,000	-14,041,000	-14,002,000	-13,993,000	-13,895,000	-13,893,000	-13,864,000	-13,862,000	-13,756,000	-13,747,000	-13,861,000	-13,978,000	-13,872,000	-13,889,000	-14,034,000	-14,150,000	-14,138,000	-14,130,000	-14,093,000	-14,067,000	-14,038,000	-14,027,000	-14,000,000	-13,963,000	-13,960,000	-13,905,000	-13,889,000	-13,863,000	-13,864,000	-13,853,000	-13,738,000	-13,722,000	-13,716,000	-13,703,000	-13,555,000	-13,515,000	-13,503,000	-13,502,000	-13,481,000	-13,653,000
contribution from noncontrolling interests																			0							0	0			0	1,000				0
deferred income taxes																					27,939,000								9,312,000	-11,646,000	6,842,000	3,038,000	-12,418,000	-13,633,000	14,358,000	9,444,000	-14,058,000	-3,105,000	5,995,000	21,236,000	-835,000	3,788,000	10,010,000	-531,000	19,081,000	10,284,000	15,009,000	5,486,000	23,876,000	7,498,000	40,321,000	4,419,000	-112,237,000	-21,213,000	2,084,000	-799,000	72,000									8,782,000	-5,110,000			-5,424,000	-3,043,000	-2,462,000	326,000	-31,674,000	-2,150,000	-1,285,000	650,000	-8,889,000	-15,000	-15,000	-15,000	1,576,000	-408,000
net (gain) loss on sales of a subsidiary, assets and other
amortization of interest rate swaps termination gain																														-5,959,000	-1,900,000	-1,899,000	-1,899,000	-1,899,000	-1,900,000	-1,899,000	-1,899,000	-1,899,000	-1,899,000	-1,900,000	-1,899,000	-1,899,000	-1,899,000	-1,899,000	-1,900,000	-3,747,000	-2,908,000	-2,907,000	-2,908,000
proceeds from the sale of discontinued operations and other																						0	0
write-down of inventories																							314,000	192,000	45,000		62,000	1,209,000	87,000		615,000	697,000	508,000		1,618,000	5,292,000	2,657,000
asset impairment																											1,491,000	11,294,000	1,480,000		69,000	91,000	462,000						3,241,000				0	222,000	1,005,000		406,000	0	3,028,000	1,688,000	600,000	-16,000	1,044,000					2,428,000	242,000				0				121,000				0
net cash flows used by operating activities																							134,390,000	4,736,000	-357,623,000				-34,202,000																																																			51,368,000	-78,504,000
net cash flows from (used by) investing activities:																							-23,254,000
net cash flows from financing activities
net (gain) loss on disposals of subsidiaries, assets and other
benefit from losses on (recovery of) receivables
increase in documentary letters of credit																										0	8,000	-2,131,000	2,141,000	-547,000	574,000	-325,000	320,000	-1,323,000	-14,330,000	-16,063,000	-9,752,000					8,768,000	-1,782,000	-13,896,000	18,663,000	-6,616,000	5,663,000	-65,485,000	60,217,000			-6,959,000	13,080,000									-80,791,000				-19,564,000				-2,998,000			-7,007,000	40,610,000	994,000	-2,988,000	-37,889,000	-14,446,000	12,527,000	17,918,000	8,289,000	-26,071,000	-1,126,000
proceeds from settlement of life insurance policies																									1,905,000	2,375,000	0
insurance proceeds																									2,000,000
proceeds from the sale of subsidiaries																									1,893,000		68,077,000	5,146,000	2,260,000			0	524,000
proceeds from the accounts receivable programs																									33,439,000
tax expense from stock plans
proceeds (payments) on sale of accounts receivable programs
acquisitions																										0	0			-1,655,000
proceeds from long-term debt transactions
short-term borrowings, net change																																		0	0	0	-20,090,000	15,294,000	-346,000	4,612,000	-11,758,000	7,648,000	-3,898,000	545,000	2,020,000	6,071,000	-47,465,000	34,915,000	-13,045,000	-19,484,000	-2,179,000	-4,162,000	44,432,000	-2,000,000	-8,856,000	-78,524,000	79,127,000	-46,681,000	-21,142,000	80,968,000	1,491,000	-633,000	2,286,000	-23,876,000	-4,021,000	-35,990,000	-3,746,000	3,950,000	34,359,000	-194,875,000	192,787,000	-49,102,000	-10,898,000	43,537,000				-5,000	-10,164,000
deferred income taxes & other long-term taxes																											15,249,000
decrease in restricted cash																											9,596,000	13,753,000	243,000				16,609,000	0	0	0	1,000		-238,000				-268,000	1,005,000	17,300,000
repayments on long-term debt																											-5,276,000	-7,127,000	-2,979,000		-2,627,000	-2,987,000	-3,161,000	-2,789,000	-2,789,000	-202,907,000	-2,909,000	-3,297,000	-2,690,000	-2,904,000	-2,444,000	-2,851,000	-1,683,000	-1,592,000	-1,551,000	-141,414,000	-61,040,000	-1,118,000	-1,284,000	-1,259,000	-15,340,000	-3,618,000	-44,584,000	-10,104,000	-8,486,000	-7,597,000	-7,390,000	-10,025,000	-5,456,000	-6,891,000	-7,567,000	-29,692,000	-785,000	-101,727,000	-292,000
proceeds from new markets tax credit transactions
cash and cash equivalents at beginning of year																											0	0	252,595,000	0	0	0	517,544,000	0	0	0	485,323,000	0	0	0	434,925,000	0	0	0	378,770,000	0	0	0	262,422,000	0	0	0	222,390,000	0	0	0	399,313,000	0	0	0	405,603,000	0	0	0	219,026,000	0	0	0	419,275,000	0	0	0	180,719,000	0	0	0	119,404,000	0	0	0	123,559,000	0	0
cash and cash equivalents at end of period																											405,260,000	64,975,000	130,209,000		-119,768,000	-69,621,000	465,167,000		102,177,000	-255,510,000	637,188,000		68,005,000	-13,074,000	326,075,000		5,456,000	-83,719,000	515,473,000		283,172,000	-101,299,000	271,396,000		17,477,000	-11,921,000	228,103,000		-21,459,000	-117,779,000	382,800,000		-7,523,000	-36,877,000	334,030,000		326,931,000	22,979,000	91,479,000		-6,857,000	-180,371,000	255,806,000		-3,040,000	-81,186,000	157,351,000		51,067,000	-61,367,000	133,478,000		-20,968,000	45,301,000	43,874,000		1,441,000
supplemental information:
noncash activities:
liabilities related to additions of property, plant and equipment																											-2,122,000	-18,352,000	48,726,000	20,306,000	-4,160,000	14,982,000	20,202,000	11,697,000
net (gain) loss on disposals of assets and other																												746,000	-228,000
decrease in cash and cash equivalents																												64,975,000	-122,386,000						102,177,000																				-21,459,000	-117,779,000	-16,513,000			-36,877,000	-71,573,000			22,979,000	-127,547,000			-180,371,000	-163,469,000														1,441,000
tax benefit from stock plans																																	-334,000		-611,000	-30,000	-25,000
changes in operating assets and liabilities:																													-120,537,000
asset acquisition																													-6,980,000
increase in restricted cash																																		27,317,000	51,000
cash and cash equivalents at end of year
noncash activities-
proceeds (payments) on sales of accounts receivable programs																															775,000
changes in other operating assets and liabilities																															7,230,000	-17,019,000	-12,294,000
decrease (increase) in restricted cash																															-13,541,000
net gain on sales of assets and other																																					-2,830,000
net (gain) loss on sales of assets and other																																	41,000
advance payments on sale of accounts receivable program																																	8,269,000
net gain on sale of a subsidiary, cost method investment and other																																										-3,324,000	14,000	-2,982,000	-25,064,000
advance payments on sale of accounts receivable programs																																				826,000	10,678,000
debt issuance and extinguishment costs
contribution from (purchase of) noncontrolling interests																																						0	0			22,000	0	15,000	-52,000	0	3,000	-5,000	15,000
net gain on sale of assets and other																																			965,000															-10,798,000															-214,000			291,000	-189,000			-25,000	-3,000		-486,000	-66,000	-1,032,000		-200,000	-265,000	-735,000
other assets																																			-9,410,000	6,644,000	-3,963,000	12,619,000	7,423,000	-172,000	3,804,000	-2,030,000	-4,172,000	5,871,000	-20,185,000	-2,234,000	-6,333,000																			-67,987,000	-39,037,000			-7,355,000	-24,019,000	-49,031,000	-8,927,000	-7,787,000	-17,134,000	-19,018,000	-4,559,000	-968,000	-535,000	-6,798,000	1,304,000	179,000	-13,823,000
other long-term liabilities																																			4,068,000	13,719,000	-5,290,000	-4,063,000	-538,000	-793,000	-4,270,000	-1,299,000	-1,381,000	-4,368,000	505,000	-3,048,000	3,364,000																			-4,765,000	5,899,000			853,000	8,956,000	1,473,000	18,200,000	5,168,000	-433,000	5,290,000	7,772,000	6,217,000	3,289,000	4,304,000	4,689,000	1,711,000	5,872,000
change in liabilities related to purchases of property, plant, and equipment
change in liabilities related to purchases of property, plant and equipment																																					7,562,000
tax expense from stock-based plans
proceeds from the sale of cost method investment																																														0	0	0	28,995,000
payments for debt issuance costs																																										-1,000	0	0	-430,000	-559,000
tax benefits from stock plans																																							-76,000	-33,000	-13,000		-141,000	-375,000	-109,000		-5,000			-1,910,000	-26,000			12,000	-65,000	-2,231,000	-71,000	-7,237,000	597,000	1,902,000	705,000	-546,000	126,000	828,000	518,000	4,308,000	2,573,000	3,220,000	881,000	5,237,000	6,589,000	2,081,000	2,987,000	10,596,000	918,000	7,683,000	2,043,000	1,374,000	2,641,000	6,576,000	1,592,000	1,886,000	2,790,000
net gain on sale of a subsidiary and other																																							277,000	-1,547,000	-467,000
accounts receivable sold																																							-47,704,000	37,872,000	-88,201,000	-3,458,000	-25,417,000	146,505,000	3,327,000						-80,604,000	56,710,000	47,785,000										10,839,000			-2,398,000	10,377,000			53,961,000	-33,544,000	82,709,000	12,546,000						14,825,000	26,059,000	179,000	42,958,000	-20,704,000
proceeds from the sale of a subsidiary																																							0	-491,000	2,845,000		0	-1,989,000	54,265,000
documentary letters of credit, net change																																							-85,826,000	105,138,000	32,410,000
capital lease additions and changes in accounts payable related to purchases of property, plant and equipment																																							4,363,000	2,457,000	5,062,000
purchase of noncontrolling interests																																																			-5,000	-11,000	-30,000		-407,000
tax benefit from stock-based plans
decrease in deposit for letters of credit
proceeds from termination of interest rate swaps																																																		0
tax benefit (expense) from stock-based plans
benefit from losses (recoveries) on receivables																																																		-3,248,000	1,401,000	-855,000	239,000					-751,000			-2,526,000
accounts receivable sold (repurchased)																																														-78,288,000	35,005,000	9,317,000	-46,614,000							13,094,000	21,994,000	-19,083,000			-10,456,000
proceeds from the sale of equity method investments																																																						6,578,000	0
decrease (increase) in deposit for letters of credit																																																		649,000	0
tax benefit (expense) from stock plans
net gain on sale of cost method investment and other
net (gain) loss on sale of cost method investment and other																																																-451,000	-26,071,000
accounts payable, accrued expenses, other payables and income taxes																																																																		123,965,000	331,428,000			-4,320,000	115,220,000	12,729,000	-145,808,000	144,230,000	51,724,000	57,572,000	-82,481,000	71,254,000	62,667,000	-20,396,000	-29,768,000	90,294,000	91,486,000
decrease in accounts receivable																																																	81,217,000											9,155,000	58,328,000
increase in inventories																																																	-100,139,000				-24,786,000		-73,750,000							60,473,000	154,400,000	238,402,000	80,621,000				-31,923,000
decrease (increase) in other assets																																																	-740,000							40,451,000	291,000
decrease in accounts payable, accrued expenses, other payables and income taxes																																																	-56,228,000				-121,167,000				-35,710,000				-37,242,000			-189,238,000	-356,366,000				-111,415,000
increase in other long-term liabilities																																																	113,000	-1,990,000	11,276,000	3,861,000	-2,704,000		-2,129,000	9,365,000	1,208,000				2,040,000	1,986,000	18,860,000	-7,995,000	-20,107,000				13,003,000
increase in deposit for letters of credit																																																					-865,000	-865,000	-865,000	-870,000	-1,523,000	308,000	-71,000
decrease (increase) in accounts receivable																																																		64,103,000			94,061,000			-25,547,000	-16,233,000	873,000
decrease (increase) in inventories																																																									-22,428,000	-18,732,000	-22,702,000
increase in accounts payable, accrued expenses, other payables and income taxes																																																		-11,125,000	38,190,000			23,470,000	33,112,000			49,398,000	131,517,000			24,667,000
decrease in other assets																																																			-7,495,000	19,463,000	2,978,000												-2,081,000
decrease in documentary letters of credit																																																							65,283,000	-11,410,000	-108,614,000		46,660,000	-41,694,000	-37,850,000			-11,826,000	-2,934,000			-2,332,000	-7,060,000
stock issued under incentive and purchase plans																																																			-71,000	1,586,000	-27,000	-447,000	105,000	9,568,000	389,000	139,000	1,066,000	8,329,000	960,000	2,189,000	-283,000	1,313,000	65,000	-3,659,000	-239,000	12,471,000	337,000	-2,952,000	-223,000	12,734,000	1,290,000	-2,433,000	4,920,000	19,509,000	1,663,000	1,696,000	2,886,000	12,402,000	1,719,000	3,611,000	3,010,000
net (gain) loss on sale of assets and other																																																				-270,000	374,000					-4,211,000
increase in accounts receivable																																																														14,784,000	282,117,000	223,083,000	172,402,000				-29,337,000
decrease in other long-term liabilities																																																											-5,808,000
net income																																																							36,220,000
adjustments to reconcile net income to cash from (used by) operating activities:
recoveries on receivables																																																									-522,000
gain on sale of assets and other																																																									-1,527,000
(gain) loss on sale of assets and other
adjustments to reconcile net earnings to cash from (used by) operating activities:
contract losses
decrease in deferred income taxes																																																														-44,967,000
net cash used by investing activities																																																											-17,358,000	-67,726,000	-48,779,000		-83,251,000	-118,919,000	-86,762,000				-87,647,000	-92,360,000	-253,226,000	-58,659,000	-26,668,000	-65,999,000	-38,574,000	-31,814,000	-29,114,000	-51,569,000	-25,428,000	-22,056,000	-18,437,000	-19,784,000	-16,479,000
net cash from (used by) financing activities																																																																										-13,006,000	16,397,000	15,510,000	-28,121,000	-64,455,000				-49,177,000
net income on sale of assets and other																																																															-107,000
contract loss reserves
accounts receivable repurchased
increase in deferred income taxes																																																												20,716,000	-8,933,000			-6,504,000	9,087,000				-25,368,000
net cash used by financing activities																																																												49,858,000	-55,082,000			-142,225,000	-38,831,000				-34,818,000			-68,163,000	-39,215,000
writedown of inventory																																																													12,931,000	16,645,000	49,086,000
decrease in inventories																																																													15,010,000
increase in other assets																																																													-12,155,000	28,574,000	4,359,000						-1,324,000
minority interests																																																														-63,000	-370,000	-163,000	46,000	-2,000	277,000	391,000	-128,000	-76,000	387,000	4,648,000	4,628,000	7,472,000	3,070,000	-578,000	245,000	662,000	-2,354,000	-1,910,000	2,858,000
net income on sale of assets
asset impairment charges
cash flows used by investing activities:
purchase of minority interests in cmc zawiercie																																																														0	0				-39,000
proceeds from issuance of long term debt																																																															29,821,000
acquisitions of other businesses, net of cash acquired																																																																6,000	-906,000
decrease in accounts receivable sold																																																																	4,397,000				38,715,000
net (gain) loss on sale of assets																																																																						305,000
purchase of interests in cmc zawiercie and subsidiaries
payments on trade financing arrangements																																																																										0	0	-55,000	-1,612,000	-6,011,000	-4,933,000	-5,860,000	-5,518,000
effect of exchange rate changes on cash and cash equivalents																																																																						121,000
changes in operating assets and liabilities, net of effect of acquisitions:
purchases of property, plant and equipment																																																																			-82,795,000	-75,257,000	-69,189,000	-84,488,000	-46,674,000	-48,269,000	-26,831,000	-38,608,000	-33,167,000	-32,355,000	-27,105,000	-42,330,000	-27,743,000	-22,926,000	-17,215,000	-18,674,000	-18,643,000
sales of property, plant and equipment																																																																			797,000	364,000	299,000		797,000	243,000	224,000		1,367,000	564,000	3,108,000		2,315,000	870,000	1,728,000
payments on long-term debt																																																																			-503,000	272,000	-1,473,000	-53,257,000	-238,000	-275,000	-18,512,000	-19,777,000			-240,000	-15,781,000	-1,018,000	-357,000	-66,000	-42,430,000	1,266,000
dividends paid																																																																			-13,693,000	-13,958,000	-10,671,000	-10,773,000	-10,733,000	-10,673,000	-7,075,000	-7,190,000	-6,017,000	-3,513,000	-3,492,000	-3,506,000	-3,627,000	-3,587,000	-2,932,000	-2,922,000	-2,322,000
purchase of interests in cmc zawiercie subsidiary																																																																									-61,000
adjustments to reconcile net earnings to cash from operating activities:
sales of property, plant and equipment and other
purchase of interests in cmc zawiercie
net cash from financing activities																																																																																15,649,000	15,942,000
acquisitions of fabrication businesses																																																																												-23,000	-5,117,000		0
loss on reacquisition of debt																																																																																		0	0
net gain on sale of assets
acquisitions of cmc zawiercie and lofland, net of cash acquired
proceeds from trade financing arrangements
debt reacquisition and issuance costs																																																																																		0	0
business interruption insurance recovery																																																																																-600,000	-3,900,000
acquisitions of cmcz and lofland, net of cash acquired																																																																																		0	392,000
acquisitions of fabrication businesses, net of cash acquired
asset impairment charge
acquisitions of lofland and cmcz, net of cash acquired
adjustments to reconcile net earnings to cash used by operating activities:
changes in operating assets and liabilities, net of effect of acquisition:
acquisition of fabrication business																																																																																	-2,950,000
short-term borrowings																																																																																	14,450,000
changes in operating assets and liabilities, net of effect of acquisitions and sale of smi-owen:
sale of assets of smi-owen
minority interest																																																																																			6,941,000
net gain on sale of property and other																																																																																			-407,000
net cash used by operating activities																																																																																			-1,488,000
sale of property, plant and equipment																																																																																			1,772,000
acquisition of symons’ denver, co. business
payments on short-term trade financing arrangement																																																																																			-3,000,000
notes payable — cmcz
proceeds from notes payable — cmcz

We provide you with 20 years of cash flow statements for Commercial Metals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Commercial Metals stock. Explore the full financial landscape of Commercial Metals stock with our expertly curated income statements.

The information provided in this report about Commercial Metals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.